Overview
Dr. Sammons is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer. She has led multiple clinical trials which have led to new treatment options for patients with metastatic breast cancer. She also has expertise in the treatment of brain metastases. Dr. Sammons received her MD from Sidney Kimmel Medical College in Philadelphia, PA in 2012. She completed her residency in internal medicine at University of Maryland and went on to complete fellowship in medical oncology and hematology at Duke University. In 2018, she joined the staff of Duke Cancer Institute and ultimately served as Associate Director of Breast Cancer Research. She joined Brigham and Women's and Dana-Farber in 2022, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. She serves as Associate Director of the Metastatic Breast Cancer Program.
Dr. Sammons is rated as an Experienced provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer.
Her clinical research consists of co-authoring 67 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- POS
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Avenue, Susan F. Smith Center For Women's Cancers, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Beth Israel Deaconess Medical Center - Hematology/Oncology
Nadine Tung is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Tung is rated as an Elite provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT).
The General Hospital Corporation
Leif Ellisen is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Ellisen is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. His top areas of expertise are Breast Cancer, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Triple-Negative Breast Cancer. Dr. Ellisen is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Judy Garber is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Garber is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Li-Fraumeni Syndrome, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Von Hippel-Lindau (VHL) Syndrome. Dr. Garber is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Sammons isElite. Learn about Breast Cancer.
- Distinguished
- HER-2 Positive Breast CancerDr. Sammons isDistinguished. Learn about HER-2 Positive Breast Cancer.
- Advanced
- AngiosarcomaDr. Sammons isAdvanced. Learn about Angiosarcoma.
- Brain TumorDr. Sammons isAdvanced. Learn about Brain Tumor.
- HER2 Negative Breast CancerDr. Sammons isAdvanced. Learn about HER2 Negative Breast Cancer.
- Inflammatory Breast CancerDr. Sammons isAdvanced. Learn about Inflammatory Breast Cancer.
- Metastatic Brain TumorDr. Sammons isAdvanced. Learn about Metastatic Brain Tumor.
- Paget Disease of the BreastDr. Sammons isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Adult Soft Tissue SarcomaDr. Sammons isExperienced. Learn about Adult Soft Tissue Sarcoma.
- BRCA Positive Breast CancerDr. Sammons isExperienced. Learn about BRCA Positive Breast Cancer.
- Heart TumorDr. Sammons isExperienced. Learn about Heart Tumor.
- MenopauseDr. Sammons isExperienced. Learn about Menopause.